Stay updated on Dolutegravir Study in Completing IMPAACT Participants Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page.

Latest updates to the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page
- CheckyesterdayChange DetectedThe page’s revision/build identifier was updated from v3.5.2 to v3.5.3, indicating a site-system update rather than a change to the clinical trial or its content.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No study details or user-facing content appear affected.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedThe page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check51 days agoChange DetectedAdded Revision: v3.4.3 label; removed Revision: v3.4.2 label.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no substantive changes to study content or functionality observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page now includes updated results information (Results First Posted 2026-02-05, Results First Submitted 2026-01-14, and related QC–posted results) and new/updated study documents (Study Protocol and SAP) to accompany the study record.SummaryDifference2%

Stay in the know with updates to Dolutegravir Study in Completing IMPAACT Participants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir Study in Completing IMPAACT Participants Clinical Trial page.